Urinalysis
News on urine-based diagnostic testing.
BioMérieux, Baxter Get CE Mark for Acute Kidney Injury Test
The immunofluorescence test detects a biomarker in a patient's urine to predict persistent severe acute kidney injury.
Clinical Lab Bluewater Toxicology to Pay $1.25M to Settle Allegations of False Claims
The US Department of Justice alleged that the Kentucky-based clinical lab had submitted false claims for urine drug testing services, among other things.
KDx Diagnostics to Launch Clinical Study of Bladder Cancer Test in Hematuria Patients
The urine-based test, which uses a novel cancer biomarker to detect new and recurrent bladder cancer, has both the CE mark and FDA breakthrough device designation.
Thermo Fisher Scientific Partners With Mindray on Drugs of Abuse Testing
Under the exclusive agreement, Thermo Fisher is distributing Mindray's BS-480 and BA-800M clinical chemistry analyzers together with its own assays in the US and Canada.
Bladder Cancer Test From KDx Diagnostics Gets CE Mark
The test leverages a novel cancer biomarker that may improve the accuracy and sensitivity of noninvasive bladder cancer testing.